Global Artificial Organ & Bionics Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Artificial Organ & Bionics Market Research Report 2024
Artificial organs and bionics are advanced medical devices or systems designed to replace or enhance the functionality of specific organs or body parts. These technologies aim to improve the quality of life for individuals with organ failure or physical disabilities.
According to MRAResearch’s new survey, global Artificial Organ & Bionics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
The market for artificial organs and bionics is driven by the increasing incidence of organ failure, chronic diseases, and physical disabilities. Advancements in bioengineering, materials science, and prosthetics have led to the development of more sophisticated and functional artificial organs, boosting the market's growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Artificial Organ & Bionics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abiomed
Asahi Kasei Kuraray Medical
Thoratec
WorldHeart
Gambro AB
Guanhao Biotech
Venus Medtech
Weigao Medical Polymer
Zhenghai Bio-Tech
Segment by Type
Mechanical Bionics
Electronic Bionics
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Artificial Organ & Bionics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Artificial Organ & Bionics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
The market for artificial organs and bionics is driven by the increasing incidence of organ failure, chronic diseases, and physical disabilities. Advancements in bioengineering, materials science, and prosthetics have led to the development of more sophisticated and functional artificial organs, boosting the market's growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Artificial Organ & Bionics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abiomed
Asahi Kasei Kuraray Medical
Thoratec
WorldHeart
Gambro AB
Guanhao Biotech
Venus Medtech
Weigao Medical Polymer
Zhenghai Bio-Tech
Segment by Type
Mechanical Bionics
Electronic Bionics
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Artificial Organ & Bionics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source